42
10
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T11829 |
LDH-IN-1
|
Dehydrogenase | Metabolism |
LDH-IN-1 是新型的基于吡唑的人乳酸脱氢酶抑制剂,对于 LDHA 和 LDHB 的 IC50 分别为32和27 nM。 | |||
T15435 |
GSK2837808A
|
Dehydrogenase | Metabolism |
GSK2837808A 是一种选择性的乳酸脱氢酶A 抑制剂,对 hLDHA (IC50:2.6 nM) 和 hLDHB (IC50:43 nM)。 | |||
T22336 |
Galloflavin
|
Dehydrogenase | Metabolism |
Galloflavin 是乳酸脱氢酶抑制剂。用 Pyruvate 法得到的 Ki 为 5.46 µM (LDH-A) 以及15.06 µM (LDH-B)。它能够阻断 ATP 的生成和糖酵解,从而抑制癌细胞的增殖。 | |||
T4295 |
(R)-GNE-140
GNE-140 |
Dehydrogenase | Metabolism |
(R)-GNE-140 (GNE-140) 是 LDHA 抑制剂,能够作用于 LDHA (IC50:3 nM) 和 LDHB (IC50:3 nM)。它的活性是 S 型异构体的 18 倍。 | |||
T12438 |
PfDHODH-IN-1
|
Dehydrogenase; Parasite | Metabolism; Microbiology/Virology |
PfDHODH-IN-1 是 Leflunomide 活性代谢物的类似物,具有抗疟疾活性。它是恶性疟原虫二氢乳清酸脱氢酶抑制剂。 | |||
T11546 |
hDHODH-IN-1
|
Dehydrogenase | Metabolism |
hDHODH-IN-1 是有效的人二氢乳清酸脱氢酶抑制剂, 显示出抗炎作用。 | |||
T3175 |
LDHA-IN-4
AZ 33,AZ-33,LDHA Inhibitor,AZ33 |
Dehydrogenase | Metabolism |
LDHA-IN-4 (AZ33) 是乳酸脱氢酶 A 选择性抑制剂,IC50=0.5 μM,Kd=0.093 μM。 | |||
T8869 | B355252 | Others | Others |
B355252 是苯氧基噻吩磺酰胺小分子,NGF 受体激动剂。它能增强 NGF 诱导的神经突生长。它可减轻 DNA 损伤、抑制 ROS 生成、降低 LDH 水平以及预防神经元凋亡,保护缺血性神经元免受神经元损失。它具有抗细胞凋亡作用。 | |||
T5325 |
Nifurtimox
硝呋替莫,BAY-2502,BAY-A-2502 |
Dehydrogenase; Parasite | Metabolism; Microbiology/Virology |
Nifurtimox (BAY-A-2502) 是一种用于锥虫病的抗虫剂,可影响乳酸脱氢酶活性。它有潜力研究神经母细胞瘤细胞。 | |||
T39308 |
Boc-Asp(OMe)-fluoromethyl ketone
Boc-Asp(OMe)-fluoromethyl ketone,Boc-Asp(OMe)-FMK |
Caspase | Apoptosis; Proteases/Proteasome |
Boc-Asp(OMe)-fluoromethyl ketone (Boc-Asp(OMe)-FMK) 是广谱的 caspase 抑制剂,可抑制 Fas 介导的吞噬作用和氧化破裂抑制,但对 IL-8 的趋化活性无影响。 | |||
T60372 |
ALDH3A1-IN-1
|
||
ALDH3A1-IN-1 (Compound 18) 是一种有效的ALDH3A1抑制剂,IC50为 1.61 μM。ALDH3A1-IN-1 比 DEAB 更有效地对抗患者来源的原发性前列腺肿瘤上皮细胞,无论是作为单药或与多西紫杉醇联合治疗。 | |||
T60240 |
ALDH1A3-IN-2
|
Dehydrogenase | Metabolism |
ALDH1A3-IN-2 是一种有效的 ALDH1A3 抑制剂,IC50 为 0.30 μM。ALDH1A3-IN-2 具有癌症疾病研究的潜力。 | |||
T39805 |
LDHA-IN-3
PSTMB,1-(phenylseleno)-4-(trifluoromethyl) benzene |
Dehydrogenase | Metabolism |
LDHA-IN-3 (1-(phenylseleno)-4-(trifluoromethyl) benzene) 是一种有效的非竞争性乳酸脱氢酶(LDHA) 抑制剂,IC50值为 145.2 nM。LDHA-IN-3 是一种硒苯化合物,可用于研究癌症。 | |||
T64347 |
ALDH1A3-IN-3
|
Dehydrogenase | Metabolism |
ALDH1A3-IN-3 (化合物 16) 是一种有效的 ALDH1A3 抑制剂,IC50 值为 0.26 μM。ALDH1A3-IN-3 也是 ALDH3A1 的底物。ALDH1A3-IN-3 可用于前列腺癌的研究。 | |||
T63341 |
ALDH1A1-IN-2
|
Dehydrogenase | Metabolism |
ALDH1A1-IN-2 是一种有效的醛脱氢酶 1a1 (aldh1a1) 抑制剂,具有抗癌活性。ALDH1A1-IN-2 可用于研究乳腺癌、炎症或肥胖症。 | |||
T67832 |
ALDH2 modulator 1
|
Dehydrogenase | Metabolism |
ALDH2 modulator 1 是一种有效的且具有口服活性的乙醛脱氢酶-2 (ALDH2)调节剂。ALDH2 modulator 1 可使小鼠血液中的酒精含量降低。 | |||
T61339 | LDHA/PDKs-IN-1 | ||
LDHA/PDKs-IN-1 (compound 20e) is a highly effective dual inhibitor of PDKs and LDHA, displaying IC50 values of 0.8 μM and 0.15 μM, respectively. It significantly suppresses A549 cell proliferation (EC50 = 13.2 μM), reduces lactate formation, and enhances oxygen consumption. This compound holds great promise for cancer research [1]. | |||
T60275 |
ALDH3A1-IN-2
|
||
ALDH3A1-IN-2 (Compound 19) 作为一种高效的ALDH3A1抑制剂,其IC50值达到1.29 μM。由于醛脱氢酶 (ALDH) 在前列腺癌等多种肿瘤类型中的过表达,ALDH3A1-IN-2 显示出其在癌症疾病研究中的应用潜力。 | |||
T60995 |
LDHA/PDKs-IN-2
|
||
LDHA/PDKs-IN-2 (compound 20k) 是有效的 LDHA 和 PDKs 的双重抑制剂,IC50 值分别为 0.7 和 1.6 μM。LDHA/PDKs-IN-2 会增加耗氧量并且减少乳酸的形成。LDHA/PDKs-IN-2 显示了癌症研究的潜力,它可以减少 A549 细胞的增殖,EC50值为 15.7 μM。 | |||
T64228 |
ALDH1A1-IN-3
|
||
ALDH1A1-IN-3 是一种良好的、选择性的醛脱氢酶 1A1 (ALDH1A1) 抑制剂 (IC50: μM)。ALDH1A1-IN-3 可以有效的改善 HepG2 细胞的葡萄糖消耗。ALDH1A1-IN-3 能够用于进行改善糖代谢的研究。 | |||
T39675 |
ALDH1A2-IN-1
ALDH1A2-IN-1 |
||
ALDH1A2-IN-1 is a reversible inhibitor of the active site of ALDH1A2, showing a significant affinity for the enzyme with an IC50 value of 0.91 μM and a Kd value of 0.26 μM. This compound interacts hydrophobically with the enzyme, contributing to its inhibitory properties. | |||
T73222 | LDHA-IN-5 | ||
LDHA-IN-5为新型且有效的GO/LDHA双重抑制剂,旨在治疗原发性高草酸尿。 | |||
T60550 |
ALDH1A3-IN-1
|
||
ALDH1A3-IN-1 (Compound 14) 是有效的 ALDH1A3抑制剂,可用于前列腺癌的研究, (IC50 = 0.63 μM; Ki = 0.46 μM)。 | |||
T19831 |
Sodium Oxamate
草氨酸钠,oxamate sodium,Oxamic acid sodium salt,Aminooxoacetic acid sodium salt,SO |
Apoptosis; Dehydrogenase; CDK | Apoptosis; Cell Cycle/Checkpoint; Metabolism |
Sodium Oxamate (Oxamic acid sodium salt) 是一种 LDH 抑制剂,对 LDHA 特异性抑制。Sodium Oxamate 具有抗肿瘤活性,可以诱导细胞周期阻滞、细胞凋亡。 | |||
T64345 |
4-(Dimethylamino)phenol
|
Others | Others |
4-(Dimethylamino)phenol enhances extracellular lactate dehydrogenase (LDH) levels without significant effects on gluconeogenesis. Only when the membrane becomes permeable to LDH does 4-(Dimethylamino)phenol reduce ATP content. | |||
T60041 |
N-[2-(5-Chloro-1H-indol-3-yl)ethyl]-4'-cyanobiphenyl-2-carboxaMide
|
Microtubule Associated | Cytoskeletal Signaling |
N-[2-(5-Chloro-1H-indol-3-yl)ethyl]-4'-cyanobiphenyl-2-carboxaMide 是一种 TAU 细胞毒性抑制剂,抑制 M17-TAU P301L 细胞的 LDH 泄漏,EC50=325nM。 | |||
T67946 |
EP2 receptor antagonist-2
|
Prostaglandin Receptor | GPCR/G Protein; Immunology/Inflammation |
EP2 receptor antagonist-2 (CID891729)为EP2受体拮抗剂,能够抑制PGE2诱导的EP2受体激活,并阻断由N-甲基-D-天冬氨酸(NMDA)引起的乳酸脱氢酶(LDH)释放。 | |||
T60400 |
LDCA
|
Apoptosis; Dehydrogenase | Apoptosis; Metabolism |
LDCA 是一种双hit 代谢调节剂,展现出强大的抗增殖活性。LDCA 能竞争性地抑制LDH-A 酶的活性,改变线粒体的超极化并同时颠覆细胞凋亡。LDCA 在癌细胞中作用明显且不显示出毒性。 | |||
T77579 |
JC2-11
|
IL Receptor; Dehydrogenase; ROS; Caspase; NOD-like Receptor (NLR); AIM2 | Apoptosis; Immunology/Inflammation; Metabolism; Proteases/Proteasome |
JC2-11 是一种对炎症有抑制作用的化合物。JC2-11 对含有募集结构域的蛋白质 NLRC 4、黑色素瘤 2 中缺失 (AIM 2) 和非典型 (NC) 炎症小体有抑制作用,通过破坏活性氧的产生和 caspase-1 的活性来抑制炎症小体的活化。JC2-11 减少了炎症小体中 caspase-1 (p20) 的分泌、gasdermin D (GSDMD) 的裂解、IL-1β 和乳酸脱氢酶 (LDH) 的释放。 | |||
T39802 |
Nedosiran
DCR-PHXC |
||
Nedosiran (DCR-PHXC) is a GalNAc-dsRNA conjugate designed for RNA interference (RNAi) targeting lactate dehydrogenase (LDH). It serves as a potential therapeutic option for patients with primary hyperoxaluria (PH) and end-stage renal disease (ESRD). | |||
T73994 | Nedosiran sodium | ||
Nedosiran sodium 是一种靶向乳酸脱氢酶 (LDH)的 RNA 干扰剂 (RNAi)。Nedosiran sodium?可用于研究并发终末期肾病 (ESRD)的原发性高草酸尿症 (PH)。 | |||
T71903 |
Meclocycline
|
||
Meclocycline is a tetracycline antibiotic with broad antimicrobial activity. Meclocycline inhibits lactate dehydrogenase (LDH) release and cell toxicity induced by expression of htt-N63-148Q, a mutant form of the huntingtin gene, without altering htt-N63-148Q protein levels in PC12 cells. | |||
T70032 |
NCI-006
|
||
NCI-006 is a potent new inhibitor of lactate dehydrogenase (LDH) that disrupts tumor growth in mice. LDH inhibition slows tumor growth but rapidly redirects pyruvate to support mitochondrial metabolism. Inhibiting both mitochondrial complex 1 and LDH suppresses metabolic plasticity of glycolytic tumors in vivo, significantly prolonging tumor growth inhibition. | |||
T61312 | Antioxidant agent-3 | ||
Antioxidant agent-3 (Compound 14q) 是一种抗氧化剂,具有有效的DPPH 自由基清除活性和ABTS+清除活性,IC50分别为 26.58 和 30.31 μM。Antioxidant agent-3 作用于 H2O2处理的 HepG2 细胞,可增加活性氧 (ROS)、超氧化物歧化酶 (SOD) 和谷胱甘肽 (GSH),并减少乳酸脱氢酶(LDH)。 | |||
T73930 | (-)-Eseroline fumarate | ||
(-)-Eseroline fumarate 是一种 AChE 抑制剂 Physostigmine 的代谢产物。(-)-Eseroline fumarate 引起癌细胞的乳酸脱氢酶 (LDH) 泄漏。(-)-Eseroline fumarate 还诱导神经元细胞释放腺嘌呤核苷酸和5-羟色胺 (5-HT),从而诱导细胞死亡。(-)-Eseroline fumarate 抑制小鼠输精管和豚鼠回肠的电诱发抽搐。 | |||
T36498 |
CAY10762
CAY10762 |
||
CAY10762 is an inhibitor of monoacylglycerol lipase (MAGL; IC50= 34.1 nM).1It reduces hydrogen peroxide-induced lactate dehydrogenase (LDH) release from Neuro2a cells when used at a concentration of 1 μM. CAY10762 (10 mg/kg) increases levels of 2-arachidonoyl glycerol in mouse brain. 1.Castelli, R., Scalvini, L., Vacondio, F., et al.Benzisothiazolinone derivatives as potent allosteric monoacylglycerol lipase inhibitors that functionally mimic sulfenylation of regulatory cysteinesJ. Med. Chem.63(... | |||
T61898 | RS6212 | ||
RS6212 是一种特异性乳酸脱氢酶 (LDH) 抑制剂(IC50= 12.03 μM)。RS6212 在多种癌细胞系中显示出强大的抗癌活性。 | |||
T76146 | D-Lactate dehydrogenase | ||
D-Lactate dehydrogenase(D-LDH)为一种氧化还原酶,以NAD+或NADP+作为受体,特异性作用于供体的CH-OH基团,催化D-乳酸氧化成丙酮酸。该酶主要分布于细菌和真菌中,是生化研究中常用的酶。 | |||
T81747 |
MS6105
|
PROTACs | PROTAC |
MS6105是一种具有抗癌活性的LDH蛋白水解靶向嵌合体(PROTAC),能够依赖时间及泛素蛋白酶体系统高效地降解LDHA和LDHB。同时,MS6105也是一个点击化学试剂,含有Alkyne基团,能与含Azide基团的分子通过铜催化的叠氮-炔环加成反应(CuAAc)发生反应。 | |||
T71305 |
Clofibric Acid-d4
|
||
Clofibric acid-d4 is intended for use as an internal standard for the quantification of clofibric acid by GC- or LC-MS. Clofibric acid is a peroxisome proliferator-activated receptor α (PPARα) agonist (EC50 = 50 µM in a transactivation assay) and the active metabolite of clofibrate. It is formed from clofibrate by tissue and serum esterases. Dietary administration of clofibric acid (0.067-0.22%) reduces serum cholesterol, phospholipid, and triglyceride levels in rats. It decreases glutamate oxal... | |||
T83768 |
Zofenoprilat
Zofenopril-SH,SQ 26,333 |
||
Zofenoprilat是一种血管紧张素转换酶(ACE; IC50 = 8 nM for the rabbit lung enzyme)的抑制剂,同时也是前体药zofenopril的活性代谢产物。它能够抑制分离的豚鼠小肠中由血管紧张素I或缓激肽诱导的收缩(EC50s = 3 and 1 nM, respectively)。在人类脐静脉内皮细胞(HUVECs)中,Zofenoprilat (10 nM)降低基础内皮素-1分泌和一氧化氮(NO)生成,并阻止TNF-α诱导的活性氧种(ROS)增加以及谷胱甘肽(GSH)水平降低。Zofenoprilat (10 µM)保护初级人类心脏微血管内皮细胞免受多柔比星诱导的细胞毒性。此外,Zofenoprilat (10 µM)还能增加HUVECs中的硫化氢(H2S)生成,以及细胞的黏着、迁移和增殖。在以400 µM浓度使用时,它可以减少Langendorff分离的大鼠心脏灌流缺血再灌注损伤模型中的舒张末压和乳酸脱氢酶(LDH)释放。 | |||
T36610 |
(E)-2-(2-Chlorostyryl)-3,5,6-trimethylpyrazine
|
||
(E)-2-(2-Chlorostyryl)-3,5,6-trimethylpyrazine (CSTMP) is a stilbene derivative with antioxidant and anticancer activities. It stimulates proliferation of hydrogen peroxide-damaged ECV-304 cells (EC50 = 24.9 nM). CSTMP reduces hydrogen peroxide-induced release of lactate dehydrogenase (LDH) in and increases viability of human umbilical vein endothelial cells (HUVECs) in a concentration-dependent manner via inhibition of apoptosis. It reverses hydrogen peroxide-induced release of malondialdehyde ... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T5705 |
Glomeratose A
|
Dehydrogenase | Metabolism |
Glomeratose A 是分离自远志Polygala tenuifolia 中,是一种乳酸脱氢酶lactate dehydrogenase 抑制剂。 | |||
T7964 |
Isomalt
异麦芽酮糖醇,Palatinitol,Palatinit |
Others; Dehydrogenase | Metabolism; Others |
Isomalt (Palatinitol) 是无毒的、具有良好耐受性的多元醇和蛋白质稳定的赋形剂,在冷冻干燥过程中可适度稳定乳酸脱氢酶(LDH),并在储存期间表现更好。它传统上在食品工业中用作甜味剂,也在制药中用作压片赋形剂。 | |||
T5S0620 |
3-Dehydrotrametenolic acid
Dehydrotrametenolic acid,松苓新酸,3-氢化去氢松苓酸 |
Apoptosis; Others; Dehydrogenase | Apoptosis; Metabolism; Others |
3-Dehydrotrametenolic acid 是从茯苓菌核分离的一种乳酸脱氢酶抑制剂,可诱导细胞凋亡,具有抗癌活性。它促进体外脂肪细胞分化,在体内起胰岛素增敏剂的作用。 | |||
T4S0779 |
D-tetrahydropalmatine
|
Others; Dopamine Receptor | GPCR/G Protein; Neuroscience; Others |
D-Tetrahydropalmatine 是一种主要存在于延胡索类植物中的异喹啉生物碱。它是有机阳离子转运蛋白 1 抑制剂。它是多巴胺受体拮抗剂,对 D1 受体具有优先亲和力。 | |||
TN1829 |
Kakkalide
|
Dehydrogenase | Metabolism |
Kakkalide 是提取自葛根花中的一种异黄酮。它可以抑制活性氧相关炎症,并改善内皮细胞胰岛素抵抗作用。 | |||
T4738 |
Sodium 2-hydroxybutanoate
2-Hydroxybutyric acid sodium salt,2-羟基丁酸钠,DL-2-Hydroxybutyric Acid Sodium Salt,alpha-hydroxybutyrate,SODIUM 2-HYDROXYBUTYRATE |
Others; Endogenous Metabolite | Metabolism; Others |
Sodium 2-hydroxybutanoate (alpha-hydroxybutyrate) 是内源性代谢产物的一种。 | |||
T5S0106 |
Peimisine
贝母辛,Ebeiensine |
RAAS; AChR | Endocrinology/Hormones; Neuroscience |
Peimisine (Ebeiensine) 非竞争性拮抗气管平滑肌 M 受体,抑制 Ach 引起的平滑肌收缩。它兴奋 β 受体和拮抗内钙释放,促进一氧化氮释放,可舒张气管平滑肌,有平喘作用。 | |||
T2S0500 |
Ilexsaponin A
毛冬青皂苷A,毛冬青皂苷甲,Ilexsaponin A1 |
Others | Others |
Ilexsaponin A (Ilexsaponin A1)1 是分离自冬凌草的根中,利用抗凋亡途径减轻缺血再灌注引起的心肌损伤。它能够减少心肌梗塞的大小,减少 LDH,AST 和 CK-MB 的血清水平,促进细胞活力并抑制缺氧/复氧心肌细胞的凋亡。 | |||
TN1298 |
6''-O-Acetylglycitin
|
Dehydrogenase | Metabolism |
6''-O-Acetylglycitin is a potential nutriceutical, it is also a potent LDH inhibitor. | |||
T83725 |
Nigerose
Sakebiose |
||
Nigerose,一种在Acremonium中发现的二糖,当与苷类化合物salidroside联合使用,浓度为150 µM时,可阻止HL-60细胞冷冻保存后的丙二醛(MDA)和活性氧物质(ROS)水平上升,并抑制乳酸脱氢酶(LDH)的释放。 |